Neuropathic pain and small fiber lesion: current state of the problem and the role of quantitative sensory testing in diagnosis

Cover Page

Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

This article provides an overview of current knowledge about the pathophysiology of peripheral neuropathic pain, modern clinical assessment and the validity of diagnostic and screening tools.

Full Text

Restricted Access

About the authors

A. A. Kunitskiy

Beloostrov Clinic of High Technologies

Author for correspondence.
Email: scvssd@yandex.ru
ORCID iD: 0009-0007-9966-0752
Russian Federation, Leningrad Region, Yukki urban settlement

O. G. Gutkina

Beloostrov Clinic of High Technologies

Email: scvssd@yandex.ru
Russian Federation, Leningrad Region, Yukki urban settlement

A. I. Skibro

Beloostrov Clinic of High Technologies

Email: scvssd@yandex.ru
Russian Federation, Leningrad Region, Yukki urban settlement

N. A. Kazakova

Beloostrov Clinic of High Technologies

Email: scvssd@yandex.ru
Russian Federation, Leningrad Region, Yukki urban settlement

Yu. V. Gaiduk

Beloostrov Clinic of High Technologies

Email: scvssd@yandex.ru

Candidate of Medical Sciences

Russian Federation, Leningrad Region, Yukki urban settlement

References

  1. Treede R.D., Rief W., Barke A. et al. Chronic pain as a symptom or a disease: the IASP Classifcation of Chronic Pain for the International Classifcation of Diseases (ICD-11). Pain. 2019; 160 (1): 19–27. doi: 10.1097/j.pain.0000000000001384
  2. IASP. Part III: Pain terms. A current list with defnitions and notes on usage. International Association for the Study of Pain (IASP). Pain terms. Proc Jpn Acad Ser B Phys Biol Sci. 2011; 93: 174–82. doi: 10.2183/pjab.93.011
  3. Freynhagen R., Parada H.A., Calderon-Ospina C.A. et al. Current understanding of the mixed pain concept: a brief narrative review. Curr Med Res Opin. 2019; 35 (6): 1011–8. doi: 10.1080/03007995.2018.1552042
  4. Attal N., Bouhassira D., Baron R. Diagnosis and assessment of neuropathic pain through questionnaires. Lancet Neurol. 2018; 17 (5): 456–66. doi: 10.1016/S1474-4422(18)30071-1
  5. Nawroth P.P., Bendszus M., Pham M. et al. The quest for more research on painful diabetic neuropathy. Neuroscience. 2018; 387: 28–37. doi: 10.1016/j.neuroscience.2017.09.023
  6. Pascal M.M.V., Themistocleous A.C., Baron R. et al. DOLORisk: study protocol for a multi-centre observational study to understand the risk factors and determinants of neuropathic pain. Wellcome Open Res. 2019; 3: 63. doi: 10.12688/wellcomeopenres.14576.2
  7. Hameed S. Nav1.7 and Nav1.8: role in the pathophysiology of pain. Mol Pain. 2019; 15: 1744806919858801. doi: 10.1177/1744806919858801
  8. Chen J., Li L., Chen Sh.-R. et al. The alpha2delta-1-NMDA receptor complex is critically involved in neuropathic pain development and gabapentin therapeutic actions. Cell Rep. 2018; 22 (9): 2307–21. doi: 10.1016/j.celrep.2018.02.021
  9. Albrecht D.S., Ahmed Sh.U., Kettner N.W. et al. Neuroinfammation of the spinal cord and nerve roots in chronic radicular pain patients. Pain. 2018; 159 (5): 968–77. doi: 10.1097/j.pain.0000000000001171
  10. Ji R.R., Nackley A., Huh Y. et al. (2018) Neuroinfammation and central sensitization in chronic and widespread pain. Anesthesiology. 2018; 129 (2): 343–66. doi: 10.1097/aln.00000 00000002130
  11. Scholz J., Finnerup N.B., Attal N. et al. The IASP classifcation of chronic pain for ICD-11: chronic neuropathic pain. Pain. 2019; 160 (1): 53–9. doi: 10.1097/j.pain.0000000000001365
  12. Vollert J., Magerl W., Baron R. et al. Pathophysiological mechanisms of neuropathic pain: comparison of sensory phenotypes in patients and human surrogate pain models. Pain. 2018; 159 (6): 1090–102. doi: 10.1097/j.pain.0000000000001190
  13. Kopf S., Groener J.B., Kender Z. et al. Deep phenotyping neuropathy: an underestimated complication in patients with pre-diabetes and type 2 diabetes associated with albuminuria. Diabetes Res Clin Pract. 2018; 146: 191–201. doi: 10.1016/j.diabres.2018.10.020
  14. Timmerman H., Wilder-Smith O.H., Steegers M.A. et al. The added value of bedside examination and screening QST to improve neuropathic pain identifcation in patients with chronic pain. J Pain Res. 2018; 11: 1307–18. doi: 10.2147/JPR.S154698
  15. Feldman E.L., Callaghan B.C., Pop-Busui R. et al. Diabetic neuropathy. Nat Rev Dis Primers. 2019; 5 (1): 41. doi: 10.1038/s41572-019-0092-1
  16. Pop-Busui R., Boulton A.J.M., Feldman E.L. et al. Diabetic neuropathy: a position statement by the American Diabetes Association. Diabetes Care. 2017; 40: 136–54. doi: 10.2337/dc16-2042
  17. Ponirakis G., Odriozolab M.N., Odriozola S. et al. NerveCheck: an inexpensive quantitative sensory testing device for patients with diabetic neuropathy. Diabetes Res Clin Pract. 2016; 113: 101–7. doi: 10.1016/j.diabres.2015.12.023
  18. Dyck P.J., Carter R.E., Litchy W.J. Modeling nerve conduction criteria for diagnosis of diabetic polyneuropathy. Muscle Nerve. 2011; 44: 340–5. doi: 10.1002/mus.22074
  19. Di Stefano G., La Cesa S., Leone C. et al. Diagnostic accuracy of laser-evoked potentials in diabetic neuropathy. Pain. 2017; 158: 1100–7. doi: 10.1097/j.pain.0000000000000889
  20. Leone C., Dufour A., Di Stefano G. et al Cooling the skin for assessing small-fibre function. Pain. 2019; 160: 1967–75. doi: 10.1097/j.pain.0000000000001584
  21. Krishnan S.T., Rayman G. The LDIflare: a novel test of C-fiber function demonstrates early neuropathy in type 2 diabetes. Diabetes Care. 2004; 27: 2930–5. doi: 10.2337/diacare.27.12.2930
  22. Alam U., Jeziorska M., Petropoulos I.N. et al. Diagnostic utility of corneal confocal microscopy and intra-epidermal nerve fibre density in diabetic neuropathy. PLoS One. 2017; 12 (7): e0180175. doi: 10.1371/journal.pone.0180175
  23. Quattrini C., Tavakoli M., Jeziorska M. et al. Surrogate markers of small fiber damage in human diabetic neuropathy. Diabetes. 2007; 56: 2148–54. doi: 10.2337/db07-0285
  24. Potockova V., Mala S., Hoskovcova L. et al. Thermal quantitative sensory testing as a screening tool for cardiac autonomic neuropathy in patients with diabetes mellitus. Brain Behav. 2022; 12 (3): e2506. doi: 10.1002/brb3.2506
  25. Guo S., Wang W., Huang H. et al. Quantitative sensory testing can effectively predict cardiovascular autonomic neuropathy in patients with type 2 diabetes mellitus. Acta Diabetol. 2021; 58 (11): 1541–9. doi: 10.1007/s00592-021-01744-4

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2024 Russkiy Vrach Publishing House